MILLENNIUM MANAGEMENT LLC - 03 Feb 2026 SCHEDULE 13G Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager
MILLENNIUM MANAGEMENT LLC
Reporting Manager
Millennium Management LLC
Security
Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
AVTX
Shares outstanding
18,505,347 shares
Disclosed Ownership
906,762 shares
Ownership
4.9%
Form type
SCHEDULE 13G
Filing time
10 Feb 2026, 16:07:24 UTC
Date of event
03 Feb 2026
Previous filing
03 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Millennium Management LLC 4.9% 906,762 0 906,762 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 4.9% 906,762 0 906,762 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 4.9% 906,762 0 906,762 /s/ Israel A. Englander Israel A. Englander